{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-048428","form_type":"8-K/A","ticker":"DFTX","cik":"0001813814","company_name":"Definium Therapeutics, Inc.","filed_at":"2023-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.375399+00:00","generated_at":"2026-06-10T16:32:48.890213+00:00","sec_items":[],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"high","headline":"Mind Medicine files 8-K/A to correct jurisdiction of incorporation to British Columbia","bullets":["Corrects prior 8-K cover page jurisdiction from erroneous entry to British Columbia, Canada.","Original Aug 14, 2023 8-K reported a loan agreement with K2 HealthVentures; this amendment does not alter that disclosure.","No financial, operational, or liquidity impact; purely administrative correction.","Company continues to trade on Nasdaq under symbol MNMD."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-048428","json":"https://secwatch.observer/filing/0000950170-23-048428.json","markdown":"https://secwatch.observer/filing/0000950170-23-048428.md","text":"https://secwatch.observer/filing/0000950170-23-048428.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023048428/0000950170-23-048428-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023048428/mnmd-20230814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T16:32:48.890213+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}